Loading...

Loading...

The Week in Health: Birmex Tender, Anvisa Pathway, and AI R&D
By Sergio Arturo Lievano Madrigal - Thu, 09/24/2026 - 15:21
Birmex's medicine tender, a COFEPRIS-Anvisa reliance pathway, public hospital upgrades, and AI in drug research shaped this Week in Health.

https://mexicobusiness.news/tag/oncology
More Health
Global Growth Fuels Boehringer Ingelheim's Mexico Bet
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 12:56
Boehringer Ingelheim's 16.2% 1H26 sales growth coincides with a 22% rise in its Mexico clinical research investment for the year.
IMSS Authorizes Two New Specialized Hospitals
By Sergio Arturo Lievano Madrigal - Fri, 06/19/2026 - 15:03
IMSS approved two new hospitals in Ecatepec and Guaymas, highlighting Mexico’s focus on specialized care, diagnostic speed and healthcare capacity.
Survey Calls for New Options for Bladder Cancer Care
By Aura Moreno - Thu, 05/21/2026 - 12:34
Global survey finds bladder cancer treatments significantly affect quality of life, highlighting demand for new therapeutic options.
Lilly to Acquire Kelonia in US$7 Billion Oncology Expansion
By Aura Moreno - Mon, 04/20/2026 - 13:28
Lilly’s US$7 billion acquisition of Kelonia expands oncology capabilities and reflects broader pharma diversification.
Mexico Accelerates Genomics Integration in Cancer Care
By Aura Moreno - Fri, 04/17/2026 - 09:50
Mexico expands precision oncology with IMOP, INCan, and IMSS initiatives improving genomic cancer diagnosis and access nationwide.
Transforming Cancer Diagnosis and Pharmacy Care With AI
By Marcos Pascual - Fri, 04/17/2026 - 08:00
Mexico’s new Women’s Cancer Hospital uses AI to optimize oncology diagnostics, telehealth, and pharmacy ecosystems, writes Marcos Pascual Cruz.
Prevention, Early Detection Could Cut Global Cancer Burden: WHO
By Aura Moreno - Thu, 02/05/2026 - 10:05
New WHO data shows nearly 40% of cancer cases are preventable, underscoring the role of early detection, policy, and system modernization.
From ATGC to F*U CANCER: CRISPR and Power to Rewrite Life’s Code
By Luis Alberto Velez - Wed, 01/28/2026 - 06:00
CRISPR-Cas9 enables precise gene editing in oncology, upgrading immune hardware to reprogram and finish cancer, writes Luis Velez.
UNAM Breast Cancer Vaccines Move Toward Human Trials
By MBN Staff - Wed, 12/31/2025 - 12:16
UNAM researchers developed therapeutic breast cancer vaccines with preclinical success, clearing the path for future human trials.
Data, Differentiation, and the Future of Healthcare in Mexico
By Aura Moreno - Wed, 12/03/2025 - 13:24
Growth comes from innovation, niche focus, and empowered teams, says Mariano Rozada, Vice President Latin America, Glenmark Pharmaceuticals.